Bryn Martin, {orange:PhD}
CTO (fractional)
Fractional CTO with {orange:deep research expertise} in cerebrospinal fluid dynamics.
Bio
Scientific Depth {orange:Behind the Platform}
Bryn Martin serves as Anuncia's fractional Chief Technology Officer, guiding the scientific and engineering direction of the ReFlow® platform. He holds a PhD with research specialisation in cerebrospinal fluid dynamics and CSF sciences.
As an adjunct academic and active researcher, Bryn brings rigorous scientific grounding to Anuncia's product development, engineering roadmap, and clinical research programme. His work connects the academic understanding of CSF flow with the engineering reality of implantable shunt systems.